BMAL1 (basic helix-loop-helix ARNT like 1) is a core circadian transcription factor that heterodimerizes with CLOCK to regulate rhythmic gene expression across multiple physiological systems 1. As a master circadian regulator, BMAL1 controls lipid metabolism, food intake, and glucose homeostasis through expression in the hypothalamus, liver, intestine, heart, and lung 2. Mechanistically, BMAL1 functions through E-box binding [GO annotations] and forms non-canonical partnerships; notably, BMAL1 heterodimerizes with HIF2A to modulate circadian hypoxic responses and regulate myocardial injury severity in a time-of-day dependent manner 3. BMAL1 also regulates mitochondrial fission and mitophagy by binding E-box elements in the BNIP3 promoter, maintaining mitochondrial oxidative phosphorylation and cardiac contractility 4. In disease contexts, BMAL1 dysregulation associates with dilated cardiomyopathy, cardiovascular disease, and thyroid aging through impaired cellular senescence control 4, 5. BMAL1 suppresses ferroptosis by repressing EGLN2 transcription and stabilizing HIF1A 6, while the CLOCK-BMAL1 complex promotes glioblastoma stem cell maintenance and immunosuppression via OLFML3 upregulation 7. Circadian disruption, manifested through BMAL1 downregulation, impairs immune responses and exacerbates viral susceptibility and inflammatory disease 8. Small molecule modulators targeting BMAL1's PASB domain show promise for therapeutic intervention 1.